Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medco’s Critical Care Systems Purchase Will Build Infusion Market Presence

Executive Summary

Medco is aiming to expand its presence in the specialty infusion market with the acquisition of Critical Care Systems, a provider of home-based and ambulatory specialty infusion services

You may also be interested in...



Health Plans Looking To Isolate Specialty Drug Costs From Medical Benefit

Health plans are moving away from traditional practices of bundling coverage for specialty drugs with physician and other medical costs, according to Medco's 2008 Drug Trend Report

Health Plans Looking To Isolate Specialty Drug Costs From Medical Benefit

Health plans are moving away from traditional practices of bundling coverage for specialty drugs with physician and other medical costs, according to Medco's 2008 Drug Trend Report

Medco PolyMedica Acquisition Expands Medicare Foothold Into Part B

Medco will establish a presence in Medicare Part B with its $1.5 billion purchase of diabetes services provider PolyMedica

Latest Headlines
See All
UsernamePublicRestriction

Register

PS049003

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel